Paragon Care's ROE % for the quarter that ended in Dec. 2025 was -13.45%. Paragon Care's PB Ratio for the quarter that ended in Dec. 2025 was 1.08.
Paragon Care's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -12.45%.
Paragon Care ROE % Adjusted to Book Value Related Terms
Paragon Care ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Paragon Care's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PXS vs MCK, CAH, COR: ROE % Adjusted to Book Value Comparison
For the Medical Distribution subindustry, Paragon Care's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care ROE % Adjusted to Book Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Paragon Care's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -12.45% mean?
Paragon Care (FRA:PXS) has a ROE % Adjusted to Book Value of -12.45% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Paragon Care and its competitors.
Is Paragon Care's ROE % Adjusted to Book Value too high?
Paragon Care's current ROE % Adjusted to Book Value is -12.45%. Overall, Paragon Care has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's ROE % Adjusted to Book Value compare to MCK and CAH?
Paragon Care's ROE % Adjusted to Book Value of -12.45% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Paragon Care and its competitors. Paragon Care's current ROE % Adjusted to Book Value is -12.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (FRA:PXS) is currently considered Possible Value Trap. The stock's GF Value™ is €0.21, compared to a current price of €0.08 — trading 60.5% below its estimated fair value. The current ROE % Adjusted to Book Value is -12.45%. Paragon Care's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Paragon Care (FRA:PXS), the current ROE % Adjusted to Book Value is -12.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (FRA:PXS) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of €0.08 is trading 60.5% below its estimated GF Value™ of €0.21.
GuruFocus considers Paragon Care to be Possible Value Trap.
Key valuation signals for FRA:PXS:
ROE % Adjusted to Book Value: -12.45%
GF Value™: €0.21 vs. price of €0.08 (60.5% below fair value)
No single metric tells the full story. See the FRA:PXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
56GF Score
Get the complete analysis for FRA:PXS
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PXS has been successfully added to your 
